arrow
T

Takafumi Mie

department of hepato-biliary-pancreatic medicine
H指数:14
被引数:810

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of subcutaneous adiposity with survival outcomes in advanced biliary tract cancer treated with gemcitabine, cisplatin, and immune checkpoint inhibitor

皮下脂肪量与接受吉西他滨、顺铂和免疫检查点抑制剂治疗的晚期胆道癌患者生存结局的关联

2026-08-140
PRE
Minor Papilla Pancreatic Duct Drainage Using a Novel Device Delivery System and Internalization of Endoscopic Nasal Pancreatic Drainage Tube With a Loop Cutter for Pancreatic Pleural Fistula in a Patient With Pancreatic Divisum

使用新型设备输送系统对副乳头胰管进行引流,并用环切器将内镜鼻胰引流管进行内部化处理,以治疗一例胰 divisum 患者的胰性胸水瘘

2026-02-180
PRE
Patient-derived orthotopic xenograft models recapitulate the peritoneal dissemination of pancreatic cancer and delineate its transcriptional and regulatory programs

患者来源的正位异种移植模型重现了胰腺癌的腹膜播散,并阐明了其转录和调控程序。

2026-02-110
OAAI
Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecan

改变转移性和复发性胰腺癌的治疗结局:纳米脂质体伊立替康可用性前后的真实世界比较

2025-12-010
PRE
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析

2025-08-300
PRE